Glibenclamide (Amglidia)

Status:

Red

Decision Date:

December 2019

Comments

RED: oral suspension for the treatment of neonatal diabetes mellitus, for use in newborns, infants and children

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again